CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor–Engineered T Cells

Walid Warda, Fabrice Larosa, Mathieu Neto Da Rocha, +14

Cancer Research

Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia

Rim Trad, Walid Warda, Vincent Alcazer, +20

Journal for ImmunoTherapy of Cancer

RapaCaspase-9-based suicide gene applied to the safety of IL-1RAP CAR-T cells

Lucie Bouquet, Elodie Bôle‐Richard, Walid Warda, +7

Gene Therapy

Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch

Walid Warda, Mathieu Neto Da Rocha, Rim Trad, +7

Cancer Gene Therapy

Droplet digital PCR allows vector copy number assessment and monitoring of experimental CAR T cells in murine xenograft models or approved CD19 CAR T cell-treated patients

Rafik Haderbache, Walid Warda, Éric Hervouet, +21

Journal of Translational Medicine

CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans

Clémentine Nicod, Mathieu Neto Da Rocha, Walid Warda, +11

Current Research in Translational Medicine